Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Xphyto Therapeutics Corp (XPHY.CN)

Xphyto Therapeutics Corp (XPHY.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 176,661
  • Shares Outstanding, K 64,240
  • Annual Sales, $ 208 K
  • Annual Income, $ -7,669 K
  • 60-Month Beta N/A
  • Price/Sales 345.40
  • Price/Cash Flow N/A
  • Price/Book 39.19
Trade XPHY.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.30
  • Most Recent Earnings -0.11 on 09/30/20
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.650 +1.89%
on 03/01/21
3.450 -21.74%
on 02/16/21
-0.300 (-10.00%)
since 02/05/21
3-Month
1.800 +50.00%
on 12/08/20
3.450 -21.74%
on 02/16/21
+0.500 (+22.73%)
since 12/04/20
52-Week
1.320 +104.55%
on 03/16/20
3.560 -24.16%
on 06/08/20
+0.900 (+50.00%)
since 03/05/20

Most Recent Stories

More News
XPhyto Completes Corporate Rebranding and Launches New Website

VANCOUVER, BC / ACCESSWIRE / March 4, 2021 / (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company"), is pleased to announce that the Company has completed a corporate rebranding and launched a new...

XPHY.CN : 2.700 (+0.37%)
XPHYF : 2.1900 (+1.39%)
With Psilocybin, Significant Progress is Being Made with Substance Use Disorders

Mental health support is not as strong as it should be for Canadians. At the moment, an overburdened ...

NUMI.VN : 1.280 (-1.54%)
LKYSF : 1.0199 (-0.98%)
MCUR.CN : 0.485 (+1.04%)
MCURF : 0.3900 (+0.31%)
SEEL : 2.60 (-2.26%)
XPHYF : 2.1900 (+1.39%)
XPHY.CN : 2.700 (+0.37%)
MSET.CN : 0.820 (-5.75%)
XPhyto Provides Updated Comments on Promotional and Marketing Activity

/ () ("or the "") at the request of IIROC and the Canadian Securities Exchange (the "") is providing additional comments to its news release and list of third-party providers dated January 22, 2021 with...

XPHY.CN : 2.700 (+0.37%)
XPHYF : 2.1900 (+1.39%)
XPhyto Places First Order for 25-Minute Covid-19 RT-PCR Tests

VANCOUVER, BC / ACCESSWIRE / February 24, 2021 / (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company"), is pleased to announce that it has placed the first order for its rapid point-of-care SARS-CoV-2...

XPHY.CN : 2.700 (+0.37%)
XPHYF : 2.1900 (+1.39%)
Proactive news headlines including GR Silver Mining, XPhyto Therapeutics, Empress Royalty and Nano One Materials

- GR Silver Mining Ltd (CVE:GRSL) (FRA:GPE) (OTCQB:GRSLF) announces first-ever ground geophysical program on San Marcial project in Sinaloa, Mexico click here

GRSLF : 0.5032 (-4.15%)
XPHY.CN : 2.700 (+0.37%)
XPHYF : 2.1900 (+1.39%)
XXMMF : 0.3054 (+3.18%)
CYDY : 4.0500 (-0.25%)
EMPR : 0.5200 (+30.00%)
EMPYF : 0.3992 (+1.99%)
GVXXF : 0.2064 (+0.58%)
ELYS : 5.17 (-6.51%)
KSHB : 1.2600 (-3.82%)
GEVO : 6.98 (-0.57%)
XPhyto Builds Commercial Team to Launch 25-Minute Covid-19 RT-PCR Test

VANCOUVER, BC / ACCESSWIRE / February 22, 2021 / (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) ("XPhyto" or the "Company"), is pleased to announce that the Company has expedited the formation of an experienced commercial...

XPHY.CN : 2.700 (+0.37%)
XPHYF : 2.1900 (+1.39%)
XPhyto Reports Vektor Pharma GMBH Lawsuit

VANCOUVER, BC / ACCESSWIRE / February 19, 2021 / (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Corporation") is providing the following comments regarding a claim made against Vektor Pharma TF GMBH...

XPHY.CN : 2.700 (+0.37%)
XPHYF : 2.1900 (+1.39%)
Proactive news headlines including American Resources, DRDGOLD Limited, LiteLink Technologies and XPhyto Therapeutics

- LiteLink Technologies Inc (CSE:LLT) (OTCMKTS:LLNKD) (FRA:C0B0) to acquire an ownership interest in Canadian cryptocurrency exchange CatalX CTS click here

LLT.CN : 0.465 (-8.82%)
LLNKD : 0.3951 (+5.98%)
CBR : 0.31 (unch)
CBGZF : 0.4400 (+0.57%)
AREC : 3.93 (+1.29%)
PMED.CN : 0.320 (+1.59%)
PMEDF : 0.2567 (+5.59%)
GBR : 4.72 (-3.08%)
GTBAF : 10.9700 (+0.11%)
GATGF : 0.3541 (-4.91%)
IDVR.CN : 0.120 (-7.69%)
CAAOF : 0.1000 (-6.19%)
NEXCF : 3.5300 (-3.02%)
NTAR.NE : 4.970 (-2.17%)
NTAR.CN : 4.430 (-4.32%)
XPHY.CN : 2.700 (+0.37%)
XPHYF : 2.1900 (+1.39%)
DRD : 9.17 (+0.55%)
XPhyto European CE-IVD Application for 25-Minute COVID-19 RT-PCR Test

VANCOUVER, BC / ACCESSWIRE / February 16, 2021 / (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company"), and its exclusive German diagnostics development partner, 3a-diagnostics GmbH ("3a"), are...

XPHY.CN : 2.700 (+0.37%)
XPHYF : 2.1900 (+1.39%)
XPhyto Adds Mescaline Production to Psychedelic Medicine Programs

VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce that XPhyto Laboratories Inc., its wholly owned Alberta subsidiary,...

XPHY.CN : 2.700 (+0.37%)
XPHYF : 2.1900 (+1.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 2.867
2nd Resistance Point 2.833
1st Resistance Point 2.767
Last Price 2.700
1st Support Level 2.667
2nd Support Level 2.633
3rd Support Level 2.567

See More

52-Week High 3.560
Fibonacci 61.8% 2.704
Last Price 2.700
Fibonacci 50% 2.440
Fibonacci 38.2% 2.176
52-Week Low 1.320

See More

Business Summary

XPhyto Therapeutics Corp is a cannabis company engaged in developing analytical testing, processing, and formulation capability in Canada. It is also engaged in research, cultivation, extraction, import, distribution, and manufacturing in Germany.

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar